Article

INP-Guided Network Pharmacology Discloses Multi-Target Therapeutic Strategy Against Cytokine and IgE Storms in the SARS-CoV-2 NB.1.8.1 Variant

2025-06-05

Abstract excerpt

<title>Abstract</title> <p>The continuous development of SARS-CoV-2 has given rise to the NB1.8.1 variant, which exhibits augmented pathogenicity, immune escape, and drug resistance against traditional therapeutics. The current study investigates a multi-layered systems pharmacology approach for identifying new therapeutic candidates that act on both viral entry and host-mediated inflammatory storms. By combining...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 54cca281-ac75-53fa-a1ef-554a0f88055c
DOI: 10.21203/rs.3.rs-6819274/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

INP-Guided Network Pharmacology Discloses Multi-Target Therapeutic Strategy Against Cytokine and IgE Storms in the SARS-CoV-2 NB.1.8.1 VariantDOI 10.21203/rs.3.rs-6819274/v1Read

A systems‐level study reveals host‐targeted repurposable drugs against SARS‐CoV‐2 infectionSemantic proximity Read

Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19Semantic proximity Read

A Connectivity Map-Based Drug Repurposing Study and Integrative Analysis of Transcriptomic Profiling of SARS-CoV-2 InfectionSemantic proximity Read

Mechanistic modeling of the SARS-CoV-2 disease mapSemantic proximity Read

Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approachSemantic proximity Read

Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19Semantic proximity Read

Bayesian model infers drug repurposing candidates for treatment of COVID-19Semantic proximity Read

Mechanistic modeling of the SARS-CoV-2 disease mapSemantic proximity Read

Research on active compounds regarding SGMD for the treatment of COVID-19 based on network pharmacology and molecular dockingSemantic proximity Read

A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infectionSemantic proximity Read

Network Medicine-Based Approach Reveals Cyclosporine and Selinexor Drug Combination as an Effective Therapy against SARS-COV-2Semantic proximity Read

Phylogenetic analysis and In silico Screening of drug targets for ACE2 in Human and Spike Glycoprotein in Sars-CoV-2 for control of COVID19Semantic proximity Read